Gwynedd Valley, PA, United States of America

Michael E Hrinda


 

Average Co-Inventor Count = 3.0

ph-index = 8

Forward Citations = 312(Granted Patents)


Location History:

  • Park Forest, IL (US) (1980)
  • Wilton, CT (US) (1985)
  • Fairfax Station, VA (US) (1989)
  • Gwynedd Valley, PA (US) (1989 - 1998)

Company Filing History:


Years Active: 1980-1998

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Michael E Hrinda: Innovator in Therapeutic Solutions

Introduction

Michael E Hrinda is a notable inventor based in Gwynedd Valley, Pennsylvania. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic solutions. With a total of 11 patents to his name, Hrinda's work focuses on innovative processes that enhance the efficacy of treatments for various medical conditions.

Latest Patents

Among Hrinda's latest patents is a groundbreaking invention related to therapeutic fragments of von Willebrand factor. This patent outlines processes for preparing aqueous solutions of cysteine-altered von Willebrand Factor fragments that are substantially free of aggregates. The process involves providing an aqueous solution of vWF fragment and denaturant, separating contaminants, and maintaining an acidic pH to enhance the therapeutic use for treating thrombosis. Another significant patent involves the production and purification of retroviral particles using a tentacle anion exchange resin. This continuous process allows for the effective production of viral particles and their purification, ensuring a steady-state log-phase growth of virally infected non-lytic cells.

Career Highlights

Hrinda has worked with prominent companies in the pharmaceutical industry, including Rhone-Poulenc Rorer Pharmaceuticals Inc. and Armour Pharmaceutical Company. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Throughout his career, Hrinda has collaborated with notable professionals in the field, including Ted C Lee and Christopher P Prior. These collaborations have likely enriched his research and development efforts, leading to the successful patents he holds today.

Conclusion

Michael E Hrinda's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to advancing therapeutic solutions. His work continues to impact the field positively, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…